208 related articles for article (PubMed ID: 32618413)
1. Hemoglobin A
McLean A; Wright F; deJong N; Skinner S; Loughlin CE; Levenson A; Carden MA
Pediatr Blood Cancer; 2020 Sep; 67(9):e28499. PubMed ID: 32618413
[TBL] [Abstract][Full Text] [Related]
2. Hemoglobin A
Chan CL; Hope E; Thurston J; Vigers T; Pyle L; Zeitler PS; Nadeau KJ
Diabetes Care; 2018 Jul; 41(7):1406-1413. PubMed ID: 29674323
[TBL] [Abstract][Full Text] [Related]
3. Glycemic monitoring in diabetics with sickle cell plus beta-thalassemia hemoglobinopathy.
Kosecki SM; Rodgers PT; Adams MB
Ann Pharmacother; 2005 Sep; 39(9):1557-60. PubMed ID: 16076916
[TBL] [Abstract][Full Text] [Related]
4. Screening for cystic fibrosis-related diabetes and prediabetes: Evaluating 1,5-anhydroglucitol, fructosamine, glycated albumin, and hemoglobin A1c.
Tommerdahl KL; Brinton JT; Vigers T; Nadeau KJ; Zeitler PS; Chan CL
Pediatr Diabetes; 2019 Dec; 20(8):1080-1086. PubMed ID: 31469470
[TBL] [Abstract][Full Text] [Related]
5. Glycated albumin in diabetic patients with chronic kidney disease.
Zheng CM; Ma WY; Wu CC; Lu KC
Clin Chim Acta; 2012 Oct; 413(19-20):1555-61. PubMed ID: 22579765
[TBL] [Abstract][Full Text] [Related]
6. Clinical validity of a self-test fructosamine in outpatient diabetic management.
Cefalu WT; Wang ZQ; Redmon E; Bell-Farrow AD; McBride D; King T
Diabetes Technol Ther; 1999; 1(4):435-41. PubMed ID: 11474829
[TBL] [Abstract][Full Text] [Related]
7. No relationship between mean plasma glucose and glycated haemoglobin in patients with cystic fibrosis-related diabetes.
Godbout A; Hammana I; Potvin S; Mainville D; Rakel A; Berthiaume Y; Chiasson JL; Coderre L; Rabasa-Lhoret R
Diabetes Metab; 2008 Dec; 34(6 Pt 1):568-73. PubMed ID: 18922724
[TBL] [Abstract][Full Text] [Related]
8. Continuous Glucose Monitoring and Use of Alternative Markers To Assess Glycemia in Chronic Kidney Disease.
Zelnick LR; Batacchi ZO; Ahmad I; Dighe A; Little RR; Trence DL; Hirsch IB; de Boer IH
Diabetes Care; 2020 Oct; 43(10):2379-2387. PubMed ID: 32788282
[TBL] [Abstract][Full Text] [Related]
9. Fructosamine--an underutilized tool in diabetes management: case report and literature review.
Youssef D; El Abbassi A; Jordan RM; Peiris AN
Tenn Med; 2008 Nov; 101(11):31-3. PubMed ID: 19024248
[TBL] [Abstract][Full Text] [Related]
10. Serum fructosamine and glycemic status in the presence of the sickle cell mutation.
Doumatey AP; Feron H; Ekoru K; Zhou J; Adeyemo A; Rotimi CN
Diabetes Res Clin Pract; 2021 Jul; 177():108918. PubMed ID: 34126128
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of agreement between hemoglobin A1c, fasting glucose, and fructosamine in Senegalese individuals with and without sickle-cell trait.
Skinner S; Diaw M; Ndour Mbaye M; Joly P; Renoux C; Masson C; Cuerq C; Lopez P; Ndour M; Diedhiou D; Sow D; Diop S; Samb A; Pialoux V; Connes P
PLoS One; 2019; 14(2):e0212552. PubMed ID: 30768636
[TBL] [Abstract][Full Text] [Related]
12. Use of large scale EHR data to evaluate A1c utilization among sickle cell disease patients.
Sivasankar S; Cheng AL; Lubin IM; Lankachandra K; Hoffman MA
BMC Med Inform Decis Mak; 2021 Sep; 21(1):268. PubMed ID: 34537047
[TBL] [Abstract][Full Text] [Related]
13. Alternate glycemic markers reflect glycemic variability in continuous glucose monitoring in youth with prediabetes and type 2 diabetes.
Chan CL; Pyle L; Kelsey MM; Newnes L; Baumgartner A; Zeitler PS; Nadeau KJ
Pediatr Diabetes; 2017 Nov; 18(7):629-636. PubMed ID: 27873436
[TBL] [Abstract][Full Text] [Related]
14. Determination of reference values for a novel ketoamine-specific fructosamine assay for assessment of diabetic glycemic control.
O'Brien JE; Brookes M
Diabetes Technol Ther; 1999; 1(4):447-55. PubMed ID: 11474831
[TBL] [Abstract][Full Text] [Related]
15. [Correlation of the Levels of Fructosamine and Glycated Hemoglobin with the Blood Glucose Profile in Pregnant Women with Diabetes Mellitus].
Fujimoto CY; da Costa RA; Zaccara Tde A; Paganotti Cde F; Francisco RP
Rev Bras Ginecol Obstet; 2016 Jan; 38(1):20-6. PubMed ID: 26814690
[TBL] [Abstract][Full Text] [Related]
16. The use of fructosamine in cystic fibrosis-related diabetes (CFRD) screening.
Lam GY; Doll-Shankaruk M; Dayton J; Rodriguez-Capote K; Higgins TN; Thomas D; Mulchey K; Smith MP; Brown NE; Leung WM; Estey MP
J Cyst Fibros; 2018 Jan; 17(1):121-124. PubMed ID: 28648493
[TBL] [Abstract][Full Text] [Related]
17. Comparison of serum fructosamine and blood glycosylated hemoglobin concentrations for assessment of glycemic control in cats with diabetes mellitus.
Elliott DA; Nelson RW; Reusch CE; Feldman EC; Neal LA
J Am Vet Med Assoc; 1999 Jun; 214(12):1794-8. PubMed ID: 10382020
[TBL] [Abstract][Full Text] [Related]
18. Results of a Study Comparing Glycated Albumin to Other Glycemic Indices.
Desouza CV; Holcomb RG; Rosenstock J; Frias JP; Hsia SH; Klein EJ; Zhou R; Kohzuma T; Fonseca VA
J Clin Endocrinol Metab; 2020 Mar; 105(3):677-87. PubMed ID: 31650161
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic value of fasting capillary glucose, fructosamine and glycosylated haemoglobin in detecting diabetes and other glucose tolerance abnormalities compared to oral glucose tolerance test.
Herdzik E; Safranow K; Ciechanowski K
Acta Diabetol; 2002 Apr; 39(1):15-22. PubMed ID: 12043934
[TBL] [Abstract][Full Text] [Related]
20. Beyond self-monitored plasma glucose and HbA1c: the role of non-traditional glycaemic markers in gestational diabetes mellitus.
Mendes N; Tavares Ribeiro R; Serrano F
J Obstet Gynaecol; 2018 Aug; 38(6):762-769. PubMed ID: 29620435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
